Top Broker Regulation Stories
ACA specialty drug prices remain problem for consumers
By Katie Kuehner-HebertThe rising out-of-pocket costs for specialty drugs within Affordable Care Act plans is most concerning.
Brokers, human resources manager and other benefits professionals were thrust into the regulatory environment with the passage of the Affordable Care Act in 2010. As health care reform continues to evolve in a post-ACA world, we provide updates on the legislative front, and analysis and advice regarding the current regulatory environment, along with insights into what's next.
The rising out-of-pocket costs for specialty drugs within Affordable Care Act plans is most concerning.